Holdings of NEA Management Company, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 23 in 2 countries
- Top ten
- 93.7 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Arcellx Inc | 3,045,262 | 349.7M $ | |
| 2 | Celcuity Inc | 2,285,561 | 260.9M $ | |
| 3 | SpyGlass Pharma Inc | 7,392,301 | 191.5M $ | |
| 4 | Trevi Therapeutics Inc | 13,222,228 | 157.7M $ | |
| 5 | Savara Inc | 24,471,264 | 133.6M $ | |
| 6 | Monte Rosa Therapeutics Inc | 7,692,298 | 126.5M $ | |
| 7 | MBX Biosciences Inc | 3,614,486 | 107.9M $ | |
| 8 | ZENAS BIOPHARMA INC | 4,023,219 | 78.7M $ | |
| 9 | Coursera Inc | 12,867,769 | 74.9M $ | |
| 10 | ORIC Pharmaceuticals Inc | 4,118,621 | 52.2M $ | |
| 11 | Phathom Pharmaceuticals Inc | 1,960,169 | 21.8M $ | |
| 12 | CVRx Inc | 2,026,083 | 19.2M $ | |
| 13 | Korro Bio Inc | 1,297,893 | 14.7M $ | |
| 14 | Champions Oncology Inc | 1,713,720 | 9.9M $ | |
| 15 | Black Diamond Therapeutics Inc | 4,448,757 | 9.5M $ | |
| 16 | Inventiva SACA | 1,462,586 | 8M $ | |
| 17 | Nkarta Inc | 3,568,781 | 7.5M $ | |
| 18 | LeonaBio Inc | 464,398 | 4.8M $ | |
| 19 | SENTI BIOSCIENCES INC | 3,775,615 | 3.1M $ | |
| 20 | MARKER THERAPEUTICS INC | 1,625,678 | 2.1M $ | |
| 21 | OnKure Therapeutics Inc | 478,548 | 2M $ | |
| 22 | Gossamer Bio Inc | 1,000,000 | 328.5K $ | |
| 23 | IMAGENEBIO INC | 50,005 | 250K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 99.5 %
- France 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 22 | 1.6B $ | 99.51 % |
| 2 | France | 1 | 8M $ | 0.49 % |
Cite this page
Titelia. "Holdings of NEA Management Company, LLC". https://titelia.com/en/funds/US13F1512848